p53 binding T cell receptor moleules and uses thereof
Details for Australian Patent Application No. 2002316190 (hide)
International Classifications
Event Publications
9 January 2003 Complete Application Filed
Priority application(s): 60/296,324 05.06.01 US
1 April 2004 Application Open to Public Inspection
Published as AU-B-2002316190
8 April 2004 Corrigenda
Applications OPI - Name Index Under the name Altor Bioscience Corporation, Application No. 2002316190, under INID (43) correct the date to read 11.03.2004.
22 January 2009 Application Accepted
Published as AU-B-2002316190
29 January 2009 Corrigenda
Applications Accepted - Name Index Under the name Altor Bioscience Corporation and The Scripps Research Institute, Application No. 2002316190, under INID(54), correct the invention title to p53 binding T cell receptor molecules and uses thereof
12 February 2009 Corrigenda
Applications Accepted - Name Index Under the Name Altor Bioscience Corporation, Application No. 2002316190, under INID (72) correct the name of the inventors to Sherman, Linda A.; Wong, Hing C.; Weidanz, Jon A. and Card, Kimberlyn F.
21 May 2009 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2002316191-PLATELET ADENOSINE DIPHOSPHATE RECEPTOR ANTAGONISTS
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser